Laura Vidal

Dose- and Schedule-Dependent Inhibition of the Mammalian Target of Rapamycin Pathway With Everolimus: A Phase I Tumor Pharmacodynamic Study in Patients With Advanced Solid Tumors

Josep Tabernero, Federico Rojo, Emiliano Calvo et al. · Journal of Clinical Oncology · 2008 · 532 citations

Medicine, Oncology, Pharmacology +17

A Phase 1 Pharmacokinetic and Pharmacodynamic Study of the Histone Deacetylase Inhibitor Belinostat in Patients with Advanced Solid Tumors

Nicola Steele, Jane A. Plumb, Laura Vidal et al. · Clinical Cancer Research · 2008 · 243 citations · Full text

Medicine, Oncology, Pharmacology +14

A Phase I Study of Intravenous Oncolytic Reovirus Type 3 Dearing in Patients with Advanced Cancer

Laura Vidal, Hardev Pandha, Timothy A. Yap et al. · Clinical Cancer Research · 2008 · 239 citations

Life Sciences, Immunology, Oncology +17

Characterization of the adaptive and innate immune response to intravenous oncolytic reovirus (Dearing type 3) during a phase I clinical trial

Charles L. White, Katie Twigger, Laura Vidal et al. · Gene Therapy · 2008 · 151 citations

Life Sciences, Immunology, Oncology +16

Two-Stage Phase I Dose-Escalation Study of Intratumoral Reovirus Type 3 Dearing and Palliative Radiotherapy in Patients with Advanced Cancers

Kevin J. Harrington, Eleni Karapanagiotou, Victoria Roulstone et al. · Clinical Cancer Research · 2010 · 121 citations · Full text

Medicine, Oncology, Radiation Oncology +17